InfuSystem Holdings, Inc., a leading national provider of infusion pumps and related services for the healthcare industry in the United States and Canada, announces today that it has closed the acquisition by its subsidiary of substantially all of the assets of Ciscura Holding Company, Inc., and its subsidiaries.  Ciscura, based in Alpharetta, GA, was a privately-held Southeastern regional provider of ambulatory infusion pumps and services to medical facilities and was the result of the previous merger of Ciscura Infusion Services and Triad Medical Supply. 

InfuSystem is acquiring approximately 1,600 infusion pumps from Ciscura, its four person field sales team, as well as its facilities management personnel, which will become the foundation of InfuSystem's new Southeast facility, located near Atlanta, Georgia. With this new regional facility, InfuSystem will be in close proximity to a number of its largest existing customers, in addition to new customers previously serviced by Ciscura, enabling same day service for equipment and supplies to much of the Southeast region. As a point of comparison, InfuSystem purchased approximately 6,000 infusion pumps in 2014.

"We are excited about the acquisition of these assets and are pleased to welcome our new Ciscura colleagues and relationships to InfuSystem," said Eric K. Steen, chief executive officer of InfuSystem.  "The addition of Ciscura further strengthens and complements InfuSystem's leading position within the oncology home infusion segment. This acquisition helps consolidate the marketplace in the CMS competitive bid environment.  Ciscura was our second largest competitor in the segment of home ambulatory pump services for chemotherapy infusion and the combined organization will feature the best of both businesses."

Mr. Steen concluded, "The acquisition of these assets will provide InfuSystem more than 100 new medical facility relationships that will allow us to offer our electronic connectivity solutions, including InfuBus paperless and work-free EMR integration. Additionally, we will be able to offer our expanded portfolio that includes pole mounted infusion pumps and disposables, such as catheter care kits and chemo safety products that meet the proposed USP 800 requirements.  This is another important milestone as we continue to expand the markets that we serve and improve InfuSystem's competitive position within the healthcare industry."